What is the appropriate evaluation and management for an otherwise healthy adult male presenting with a single episode of hematospermia?

Hematospermia Management

For an otherwise healthy adult male under 40 years presenting with a single episode of hematospermia, imaging is not indicated—reassurance after basic clinical assessment is the appropriate management. 1

Age-Based Risk Stratification

The most critical factor determining evaluation intensity is age 40 as the cutoff:

• Under 40 years: Malignancy risk is extraordinarily low (0.01%) 2
• 40 years and older: Cancer risk increases to 0.11%, with prostate cancer being the primary concern 2

The overall malignancy rate in hematospermia is only 3.5% in the general population, with a range of 0-13.1% across studies 1. In patients under 40, testicular cancer represents the rare exception, occurring in approximately 2% 3.

Recommended Evaluation for Single Episode (Age <40)

Clinical assessment should include:

• History: Exclude partner's blood (postcoital), differentiate from hematuria, assess for recent trauma or vigorous sexual activity, screen for bleeding disorders or anticoagulation use 1
• Physical examination: Testicular examination to exclude masses, digital rectal examination (DRE) for prostate tenderness suggesting prostatitis 3
• Laboratory testing:
  • Urinalysis to exclude hematuria 3, 2
  • Consider sexually transmitted infection testing if risk factors present 4
  • Blood pressure and coagulation profile if systemic bleeding concerns 1

Imaging is usually not recommended for this population with transient, isolated hematospermia 1. The 2025 ACR Appropriateness Criteria explicitly state there is no evidence supporting CT abdomen/pelvis (with or without contrast) in adults under 40 with transient hematospermia 1.

When to Escalate Evaluation

Refer or investigate further if:

• Age ≥40 years: Requires prostate-specific antigen (PSA) testing and DRE to screen for prostate cancer 1
• Recurrent episodes: Not self-limited, warrants urologic referral 3
• Associated symptoms: Fever, chills, weight loss, bone pain, lower urinary tract symptoms, or abnormal testicular examination 4, 5
• Elevated PSA or abnormal DRE findings 3
• Persistent hematospermia beyond 4 weeks 5

Evidence Quality and Common Pitfalls

The most robust data comes from a large U.S. claims database study of 56,157 patients showing that 90% of hematospermia cases have no identifiable cause and 85% of patients are safely discharged after initial review 3, 2. The 2025 ACR guidelines reinforce that most cases are idiopathic or due to benign seminal vesicle bleeding, with infectious/inflammatory processes (prostatitis, seminal vesiculitis) being the most common identifiable etiology 1.

Critical pitfalls to avoid:

• Over-investigation in young patients: Flexible cystoscopy and abdominal ultrasound have essentially zero diagnostic yield 3. Even scrotal ultrasound is rarely indicated unless testicular mass is palpated
• Unnecessary patient anxiety: The condition is self-limited in the vast majority of cases; explicit reassurance is therapeutic 4, 6
• Missing the age threshold: Patients ≥40 require PSA screening due to the association with prostate cancer 1

Treatment Approach

For isolated hematospermia in patients under 40 with normal examination and urinalysis:

• Reassurance is the primary intervention 3, 2
• Empiric antibiotics may be considered if infectious symptoms present (dysuria, frequency, prostate tenderness) 1
• Observation period: Most cases resolve spontaneously; follow-up only if symptoms persist or recur 3

The sexual ramifications of hematospermia—including anxiety, erectile dysfunction concerns, and partner distress—should be explicitly addressed during counseling 6.